What is TuHURA Biosciences Inc?
, a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies. The company's lead product candidate includes IFx2. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 82.20M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.